Atlas Trials

A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects

Clinical trial NCT05225974 · COMPLETED

Trial details

NCT number
NCT05225974
Sponsor
The Affiliated Hospital of Qingdao University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Therapeutic Equivalency
Start date
2021-07-16
Primary completion
2021-07-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.